Published in J Exp Med on January 11, 2010
Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst (2013) 3.07
The integration of T cell migration, differentiation and function. Nat Rev Immunol (2013) 2.42
Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells. Nature (2012) 2.38
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell (2013) 2.18
Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node. Immunity (2013) 1.65
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype. J Exp Med (2012) 1.32
CD8(+) T cell response to adenovirus vaccination and subsequent suppression of tumor growth: modeling, simulation and analysis. BMC Syst Biol (2015) 1.12
Annular PIP3 accumulation controls actin architecture and modulates cytotoxicity at the immunological synapse. J Exp Med (2013) 1.09
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun (2014) 1.07
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat Immunol (2015) 1.07
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun (2015) 1.06
Toward integrative cancer immunotherapy: targeting the tumor microenvironment. J Transl Med (2012) 1.04
Killing of targets by CD8 T cells in the mouse spleen follows the law of mass action. PLoS One (2011) 1.04
STIM1 and STIM2-mediated Ca(2+) influx regulates antitumour immunity by CD8(+) T cells. EMBO Mol Med (2013) 1.04
Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy. Immunol Rev (2014) 1.03
Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice. PLoS One (2010) 1.02
GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability. Cancer Immunol Res (2013) 1.02
Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice. PLoS Pathog (2010) 1.00
A general functional response of cytotoxic T lymphocyte-mediated killing of target cells. Biophys J (2014) 0.99
Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo? PLoS Comput Biol (2011) 0.95
IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization. Proc Natl Acad Sci U S A (2014) 0.93
3D porous chitosan-alginate scaffolds: a new matrix for studying prostate cancer cell-lymphocyte interactions in vitro. Adv Healthc Mater (2012) 0.92
Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy. PLoS One (2011) 0.90
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade. J Immunother Cancer (2015) 0.87
The memory of a killer T cell: models of CD8(+) T cell differentiation. Immunol Cell Biol (2015) 0.86
Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology. Int J Clin Oncol (2010) 0.85
Pathogen-related differences in the abundance of presented antigen are reflected in CD4+ T cell dynamic behavior and effector function in the lung. J Immunol (2014) 0.85
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells. Cancer Immunol Res (2016) 0.82
Spatial heterogeneity and peptide availability determine CTL killing efficiency in vivo. PLoS Comput Biol (2014) 0.80
Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates. Cancer Immunol Res (2014) 0.80
Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma. Neuro Oncol (2015) 0.79
Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion. Immunity (2016) 0.79
Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells. BMC Cancer (2013) 0.79
T Cell Vaccinology: Beyond the Reflection of Infectious Responses. Trends Immunol (2016) 0.77
Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study. J Immunother Cancer (2015) 0.77
How many neutrophils are enough (redux, redux)? J Clin Invest (2012) 0.76
How is the effectiveness of immune surveillance impacted by the spatial distribution of spreading infections? Philos Trans R Soc Lond B Biol Sci (2015) 0.76
A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents. Cancer Immunol Immunother (2016) 0.75
T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy. Lab Invest (2017) 0.75
A biased competition theory of cytotoxic T lymphocyte interaction with tumor nodules. PLoS One (2015) 0.75
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science (2002) 19.77
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology (1968) 11.20
Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell (1988) 8.01
Redefining chronic viral infection. Cell (2009) 6.30
Cell and environment interactions in tumor microregions: the multicell spheroid model. Science (1988) 6.02
Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. J Exp Med (1974) 5.37
Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer (2003) 4.99
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med (2008) 3.35
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol (1996) 2.58
Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. I. Resolution and characterization. J Immunol (1975) 1.79
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci (1992) 1.54
Role of matrix metalloproteinases in melanoma cell invasion. Biochimie (2005) 1.54
A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci U S A (2002) 1.52
CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. J Immunol (1998) 1.50
Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J Exp Med (2004) 1.38
Correlation between cell deformability and metastatic potential in B16-F1 melanoma cell variants. Cancer Res (1988) 1.37
Diversity and recognition efficiency of T cell responses to cancer. PLoS Med (2004) 1.36
Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc Natl Acad Sci U S A (2007) 1.33
Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer (1978) 1.30
THE ISOLATION AND CYTOLOGY OF TWO PIGMENT CELL STRAINS FROM B-16 MOUSE MELANOMAS. Cancer Res (1964) 1.19
Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay: independent regulation of cytokine secretion and short-term killing. Nat Med (2003) 1.17
PD-1 blockade: rescue from a near-death experience. Nat Immunol (2006) 1.11
Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment. Am J Pathol (2007) 1.11
Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun. Biochem Pharmacol (2004) 1.10
Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. J Immunol (1999) 1.10
Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. J Immunol Methods (1986) 1.05
Suppressive influences in the immune response to cancer. J Immunother (2009) 0.99
Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am J Physiol (1998) 0.94
T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging. J Immunother (2007) 0.93
Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection. Clin Immunol (2001) 0.91
Plasma proteins in a standardised skin mini-erosion (I): permeability changes as a function of time. BMC Dermatol (2002) 0.89
Accumulation in tumor tissue of adoptively transferred T cells: A comparison between intravenous and intraperitoneal injection. J Immunother (2006) 0.86
Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A. J Clin Invest (1967) 0.86
Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditions. J Exp Med (1984) 0.85
Tissue disaggregation of human renal cell carcinoma with further isopyknic and isokinetic gradient purification. Cancer Res (1980) 0.83
Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation. Am J Pathol (1984) 0.81
Separation and characterization of the neoplastic and stromal elements of the R3230AC mammary adenocarcinoma. Cancer Res (1981) 0.81
Anti-tumoural activity of peripheral blood mononuclear cells against melanoma cells: discrepant in-vitro and in-vivo effects. Melanoma Res (2006) 0.78
Growth characteristics of murine B16 melanoma multicellular spheroids: a model for invasion and effects of doxorubicin treatments. Anticancer Res (1993) 0.78
Evaluation of matrix metalloproteinases and serine proteases activities in three B16 melanoma cell lines with distinct tumorigenic potential. Anticancer Res (1994) 0.77
Collagen content of normal connective tissue, of tissue surrounding a tumour and of growing rat sarcoma. Nature (1959) 0.77
Pillars Article: Cell Type-Specific Chromatin Structure Determines the Targeting of V(D)J Recombinase Activity In Vitro. Cell. 1996. 85: 887-897. J Immunol (2015) 4.98
Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med (2003) 4.77
Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity (2005) 2.57
CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol (2002) 2.22
Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy. Clin Cancer Res (2007) 2.20
Immune complex-mediated antigen presentation induces tumor immunity. J Clin Invest (2002) 2.13
Antigenic targeting of the human mannose receptor induces tumor immunity. J Immunol (2007) 1.93
Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol (2008) 1.83
Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia (2002) 1.81
Therapeutic targeting of Syk in autoimmune diabetes. J Immunol (2010) 1.69
A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci U S A (2002) 1.52
Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest (2007) 1.51
FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J Immunol (2006) 1.42
RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol (2008) 1.41
Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J Exp Med (2004) 1.38
Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol (2007) 1.36
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2014) 1.35
Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol (2011) 1.32
Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology (2012) 1.31
Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment. Nat Immunol (2013) 1.28
Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J Immunol (2007) 1.26
H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia. Cancer Cell (2012) 1.19
Neurodegeneration and inflammation in Parkinson's disease. Parkinsonism Relat Disord (2012) 1.19
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. J Clin Invest (2003) 1.17
Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci (2008) 1.17
Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J Immunol (2007) 1.13
Teachers' participation in research programs improves their students' achievement in science. Science (2009) 1.10
RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS One (2012) 1.09
Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia. Am J Pathol (2007) 1.05
Toward integrative cancer immunotherapy: targeting the tumor microenvironment. J Transl Med (2012) 1.04
Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection. J Immunol (2008) 1.04
Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin (2012) 1.03
The bacterial peptide N-formyl-Met-Leu-Phe inhibits killing of Staphylococcus epidermidis by human neutrophils in fibrin gels. J Immunol (2002) 1.02
Different G(i)-coupled chemoattractant receptors signal qualitatively different functions in human neutrophils. J Leukoc Biol (2002) 0.99
Human cloning: scientific, ethical and Jewish perspectives. Assia Jew Med Ethics (1998) 0.97
Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice. Am J Pathol (2010) 0.97
The promise of EPC-based therapies on vascular dysfunction in diabetes. Eur J Pharmacol (2011) 0.91
PAF-receptor antagonists, lovastatin, and the PTK inhibitor genistein inhibit H2O2 secretion by macrophages cultured on oxidized-LDL matrices. J Leukoc Biol (2005) 0.90
A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose. Vaccine (2012) 0.89
Neuroinflammation in Parkinson's disease animal models: a cell stress response or a step in neurodegeneration? Curr Top Behav Neurosci (2015) 0.85
Gemfibrozil inhibits Legionella pneumophila and Mycobacterium tuberculosis enoyl coenzyme A reductases and blocks intracellular growth of these bacteria in macrophages. J Bacteriol (2009) 0.85
CD8 T cell-mediated lung damage in response to the extracellular pathogen pneumocystis is dependent on MHC class I expression by radiation-resistant lung cells. J Immunol (2005) 0.85
Pneumocystis infection in an immunocompetent host can promote collateral sensitization to respiratory antigens. Infect Immun (2011) 0.83
CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice. Eur J Immunol (2014) 0.82
The genetics of alopecia areata: What's new and how will it help our patients? Dermatol Ther (2011) 0.82
Type I interferon signaling and B cells maintain hemopoiesis during Pneumocystis infection of the lung. J Immunol (2007) 0.81
Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells. J Immunol (2009) 0.81
Histone deacetylase (HDAC) inhibitors down-regulate endothelial lineage commitment of umbilical cord blood derived endothelial progenitor cells. Int J Mol Sci (2012) 0.79
A requirement for the p85 PI3K adapter protein BCAP in the protection of macrophages from apoptosis induced by endoplasmic reticulum stress. J Immunol (2011) 0.79
Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells. J Immunol (2012) 0.78
Histone acetylation regulates the expression of HoxD9 transcription factor in endothelial progenitor cells. Rom J Morphol Embryol (2015) 0.77
Maternal-fetal cell transfer in surrogacy: ties that bind. Am J Bioeth (2014) 0.76
Liraglutide protects Rin-m5f β cells by reducing procoagulant tissue factor activity and apoptosis prompted by microparticles under conditions mimicking Instant Blood-Mediated Inflammatory Reaction. Transpl Int (2014) 0.76
How many neutrophils are enough (redux, redux)? J Clin Invest (2012) 0.76
Cultural influences on transnational gestational surrogacy. Am J Bioeth (2014) 0.75
Postmortem fatherhood: life after life. Lancet (2008) 0.75
Numerical and experimental modal analysis of the reed and pipe of a clarinet. J Acoust Soc Am (2003) 0.75
How teaching matters. CBE Life Sci Educ (2006) 0.75
Mechanical model of the inspiratory pump. J Biomech (2002) 0.75
BioCEP - a model educational program for cross-cultural bioethics. Camb Q Healthc Ethics (2012) 0.75